73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Insurance status mediates racial, ethnic inequities in cervical cancer, finds study

Insurance status mediates racial, ethnic inequities in cervical cancer, finds study

by Elana GotkineInsurance status mediates racial and ethnic inequities in advanced-stage cervical cancer diagnosis, according to a study published online March 10 inJAMA Network Open.Hunter K. H

Insurance status mediates racial, ethnic inequities in cervical cancer, finds study

by Elana GotkineInsurance status mediates racial and ethnic inequities in advanced-stage cervical cancer diagnosis, according to a study published online March 10 inJAMA Network Open.Hunter K. H
Prostate cancer: Can AI help to avoid unnecessary biopsies?

Prostate cancer: Can AI help to avoid unnecessary biopsies?

byGerman Cancer Research CenterRisk stratification example from the test cohort: a 66-year-old male presents with negative DRE, PSA elevation to 6.2 ng/mL, prostate volume of 82.5 mL, and PSAD o

Prostate cancer: Can AI help to avoid unnecessary biopsies?

byGerman Cancer Research CenterRisk stratification example from the test cohort: a 66-year-old male presents with negative DRE, PSA elevation to 6.2 ng/mL, prostate volume of 82.5 mL, and PSAD o
Treatment beneficial for nonagenarians with lung cancer

Treatment beneficial for nonagenarians with lung cancer

(HealthDay)—Receiving treatment is associated with better survival for nonagenarians with non-small cell lung cancer (NSCLC), with the greatest survival benefit for stage I patients, according to a st

Treatment beneficial for nonagenarians with lung cancer

(HealthDay)—Receiving treatment is associated with better survival for nonagenarians with non-small cell lung cancer (NSCLC), with the greatest survival benefit for stage I patients, according to a st
New hormonal agent may slow progression of early-stage prostate cancer during active surveillance

New hormonal agent may slow progression of early-stage prostate cancer during active surveillance

byWolters Kluwer HealthPositive biopsy-free survival with 95% confidence limits (shaded gray areas). Credit:Journal of Urology(2023). DOI: 10.1097/JU.0000000000003038For men with ear

New hormonal agent may slow progression of early-stage prostate cancer during active surveillance

byWolters Kluwer HealthPositive biopsy-free survival with 95% confidence limits (shaded gray areas). Credit:Journal of Urology(2023). DOI: 10.1097/JU.0000000000003038For men with ear
A new strategy 'raises the volume' of gut-body communication

A new strategy 'raises the volume' of gut-body communication

by Ana María Rodríguez, Ph.d.,Baylor College of MedicineCredit: CC0 Public DomainThroughout the gastrointestinal tract there are specialized hormone-producing cells called enteroendocrine cells

A new strategy 'raises the volume' of gut-body communication

by Ana María Rodríguez, Ph.d.,Baylor College of MedicineCredit: CC0 Public DomainThroughout the gastrointestinal tract there are specialized hormone-producing cells called enteroendocrine cells
Scientists target glioma cancer stem cells, which could improve patient survival

Scientists target glioma cancer stem cells, which could improve patient survival

by Dartmouth-Hitchcock Medical CenterThis photo illustrates the effect of secretion inhibitors on the growth of high-grade glial tumors in mice. The top row show tumors grown in the absence of se

Scientists target glioma cancer stem cells, which could improve patient survival

by Dartmouth-Hitchcock Medical CenterThis photo illustrates the effect of secretion inhibitors on the growth of high-grade glial tumors in mice. The top row show tumors grown in the absence of se
New molecule reduces the aggressiveness of pediatric cancer

New molecule reduces the aggressiveness of pediatric cancer

by André Julião,FAPESPA microRNA inhibitor identified by researchers at the FAPESP-supported Human Genome and Stem Cell Research Center reduced the sizes of aggressive tumors and improved

New molecule reduces the aggressiveness of pediatric cancer

by André Julião,FAPESPA microRNA inhibitor identified by researchers at the FAPESP-supported Human Genome and Stem Cell Research Center reduced the sizes of aggressive tumors and improved
Intraventricular immunovirotherapy: A translational step forward

Intraventricular immunovirotherapy: A translational step forward

by Impact JournalsPutative mechanisms of toxicity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28343A new research perspective titled "Intraventricular immunovirotherapy; a tran

Intraventricular immunovirotherapy: A translational step forward

by Impact JournalsPutative mechanisms of toxicity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28343A new research perspective titled "Intraventricular immunovirotherapy; a tran
Researchers find new biomarker for breast cancer

Researchers find new biomarker for breast cancer

by Austrian Science Fund (FWF)Mammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainWith the support of the FWF, an oncologist found a biomarker for bre

Researchers find new biomarker for breast cancer

by Austrian Science Fund (FWF)Mammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainWith the support of the FWF, an oncologist found a biomarker for bre
High levels of depression found among Canadian older adults with cancer during the COVID-19 pandemic

High levels of depression found among Canadian older adults with cancer during the COVID-19 pandemic

by University of TorontoCredit: Unsplash/CC0 Public DomainOlder adults who have had cancer had a high risk of experiencing symptoms of depression during the early months of the COVID-19 pandemic

High levels of depression found among Canadian older adults with cancer during the COVID-19 pandemic

by University of TorontoCredit: Unsplash/CC0 Public DomainOlder adults who have had cancer had a high risk of experiencing symptoms of depression during the early months of the COVID-19 pandemic
Remote telemedicine tool found highly accurate in diagnosing melanoma

Remote telemedicine tool found highly accurate in diagnosing melanoma

byNYU Langone HealthResearchers believe that using telemedicine for dermatology may also help avoid trips to specialists for lesions that turn out to be benign. Credit: Haley RicciardiCollecting

Remote telemedicine tool found highly accurate in diagnosing melanoma

byNYU Langone HealthResearchers believe that using telemedicine for dermatology may also help avoid trips to specialists for lesions that turn out to be benign. Credit: Haley RicciardiCollecting
Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

by Tsinghua University PressThis schematic illustrates the process of developing patient-derived skin tumor organoids from Dermatofibrosarcoma Protuberans (DFSP). The workflow includes organoid cultur

Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

by Tsinghua University PressThis schematic illustrates the process of developing patient-derived skin tumor organoids from Dermatofibrosarcoma Protuberans (DFSP). The workflow includes organoid cultur